SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-178939
Filing Date
2020-06-25
Accepted
2020-06-25 16:10:49
Documents
6
Effectiveness Date
2020-06-25

Document Format Files

Seq Description Document Type Size
1 S-8 d901453ds8.htm S-8 76722
2 EX-5.1 d901453dex51.htm EX-5.1 8903
3 EX-23.1 d901453dex231.htm EX-23.1 7861
4 EX-99.4 d901453dex994.htm EX-99.4 46573
5 GRAPHIC g901453g66d93.jpg GRAPHIC 3180
6 GRAPHIC g901453g92f83.jpg GRAPHIC 2804
  Complete submission text file 0001193125-20-178939.txt   149726
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239429 | Film No.: 20989376
SIC: 2836 Biological Products, (No Diagnostic Substances)